Core Viewpoint - *ST Sailong (002898.SZ) has experienced a significant surge in stock price despite poor performance, attributed to plans for a change in control [1][5][6]. Group 1: Stock Performance - Since April 29, *ST Sailong's stock price has skyrocketed from a low of 5.77 yuan to 10.71 yuan, marking a substantial increase [1]. - The stock has hit the daily limit up for six consecutive trading days, reflecting strong market interest [3][6]. Group 2: Ownership Change - On May 20, *ST Sailong announced a share transfer agreement where controlling shareholders Cai Nanguai and Tang Lin plan to transfer 14.16% of their shares to Hainan Yayi [5]. - The share price for this transaction is set at 8 yuan per share, totaling approximately 199 million yuan [5]. - If the transaction proceeds, Hainan Yayi will become the controlling shareholder, and *ST Sailong will transition to having no actual controller [5]. Group 3: Financial Performance - *ST Sailong reported a revenue of approximately 264 million yuan for 2024, a year-on-year decline of 15.15%, with a net profit of -33.14 million yuan, indicating a shift from profit to loss [16]. - The company has faced continuous losses over the past five years, with only one profitable year in 2023 [16][17]. - The first quarter of 2024 showed a revenue of about 54.09 million yuan, down 22.16% year-on-year, with a net profit of -1.04 million yuan [17]. Group 4: New Investor Background - Hainan Yayi, established specifically for this transaction, has a notable partnership structure, including significant players in the biopharmaceutical investment sector [10][11]. - Chen Zhansheng, a key figure in the new investment group, is associated with the well-known Libai Group, indicating potential financial strength and resources for *ST Sailong [19][21].
这家A股上市公司筹划易主,潮汕日化二代入局!股价连续6天涨停